MoneyWorks4Me

Parabolic Drugs informs about updates

22 Dec 2017 Evaluate

Parabolic Drugs has informed that with reference to e-mail dated 21-12-2017, in regard to deficiency observed in the financial result for the Quarter/Half year ended on 30th September, 2017 with respect to the point, Reconciliation of Profit and Loss not submitted.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..